Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Kiniksa Pharmaceuticals International (KNSA) Return on Assets (2021 - 2025)

Kiniksa Pharmaceuticals International's Return on Assets history spans 5 years, with the latest figure at 0.04% for Q4 2025.

  • For Q4 2025, Return on Assets fell 3.0% year-over-year to 0.04%; the TTM value through Dec 2025 reached 0.04%, down 3.0%, while the annual FY2025 figure was 0.04%, 3.0% down from the prior year.
  • Return on Assets reached 0.04% in Q4 2025 per KNSA's latest filing, down from 0.11% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.92% in Q3 2022 to a low of 0.22% in Q3 2023.
  • Average Return on Assets over 5 years is 0.15%, with a median of 0.15% recorded in 2024.
  • Peak YoY movement for Return on Assets: crashed -114bps in 2023, then skyrocketed 37bps in 2024.
  • A 5-year view of Return on Assets shows it stood at 0.03% in 2021, then skyrocketed by 580bps to 0.18% in 2022, then rose by 17bps to 0.21% in 2023, then plummeted by -106bps to 0.01% in 2024, then crashed by -217bps to 0.04% in 2025.
  • Per Business Quant, the three most recent readings for KNSA's Return on Assets are 0.04% (Q4 2025), 0.11% (Q3 2025), and 0.07% (Q2 2025).